Dr. med. Katrin-Elisabeth Schimke
Missing the boat: fatal ending to a missed case of Charcot arthropathy
Galeazzi Rech A, Stüve Y, Toepfer A, Schimke K. Missing the boat: fatal ending to a missed case of Charcot arthropathy. Endocrinol Diabetes Metab Case Rep 2020; 2020
16.06.2020Missing the boat: fatal ending to a missed case of Charcot arthropathy
16.06.2020Endocrinol Diabetes Metab Case Rep 2020; 2020
Galeazzi Rech Anna Luiza, Stüve Yvon, Toepfer Andreas, Schimke Katrin-Elisabeth
Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry
Schimke K, Renström F, Meier S, Stettler C, Brändle M, SwissDiab Study Group. Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry. BMJ Open Diabetes Res Care 2018; 6:e000454.
21.02.2018Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry
21.02.2018BMJ Open Diabetes Res Care 2018; 6:e000454
Schimke Katrin-Elisabeth, Renström Frida, Meier Sandro, Stettler Christoph, Brändle Michael, SwissDiab Study Group
Management und Prävention von Fussproblemen bei Patienten mit Diabetes
Schimke K, Chappuis B, Egli M, Hagon-Traub I, Malacarne S, Schönenweid C, Peter-Riesch B. Management und Prävention von Fussproblemen bei Patienten mit Diabetes. Swiss Medical Forum 2016; 2016/2829:578-583.
13.07.2016Management und Prävention von Fussproblemen bei Patienten mit Diabetes
13.07.2016Swiss Medical Forum 2016; 2016/2829:578-583
Schimke Katrin-Elisabeth, Chappuis Bernard, Egli Marc, Hagon-Traub Isabelle, Malacarne Sarah, Schönenweid Claude, Peter-Riesch Bettina
Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study
Schimke K, Chubb S, Davis W, Davis T. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis 2010; 212:321-6.
01.09.2010Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study
01.09.2010Atherosclerosis 2010; 212:321-6
Schimke Katrin-Elisabeth, Chubb Stephen A P, Davis Wendy A, Davis Timothy M E
Inhaled human insulin (Exubera®): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus
Schimke K, Davis T. Inhaled human insulin (Exubera®): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus. Expert Review of Clinical Pharmacology 2009; 1:13-25.
04.12.2009Inhaled human insulin (Exubera®): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus
04.12.2009Expert Review of Clinical Pharmacology 2009; 1:13-25
Schimke Katrin-Elisabeth, Davis Timothy Marc Earls
Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration
Schimke K, Greminger P, Brändle M. Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009; 117:649-51.
01.11.2009Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration
01.11.2009Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009; 117:649-51
Schimke Katrin-Elisabeth, Greminger Peter, Brändle Michael
Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study
Schimke K, Chubb S, Davis W, Phillips P, Davis T. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study. Diabetic medicine : a journal of the British Diabetic Association 2009; 26:70-5.
01.01.2009Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study
01.01.2009Diabetic medicine : a journal of the British Diabetic Association 2009; 26:70-5
Schimke Katrin-Elisabeth, Chubb S A P, Davis W A, Phillips P, Davis T M E
Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes
Schimke K, Davis T. Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes. Current opinion in investigational drugs (London, England : 2000) 2007; 8:338-44.
01.04.2007Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes
01.04.2007Current opinion in investigational drugs (London, England : 2000) 2007; 8:338-44
Schimke Katrin-Elisabeth, Davis Timothy M E
Seltene Differentialdiagnose von EKG-Veränderungen und erhöhtem Troponin
Schimke K, Clerici T, Galeazzi R, Pavlicek V. Seltene Differentialdiagnose von EKG-Veränderungen und erhöhtem Troponin. Swiss Medical Forum 2004; 4:285-287.
04.03.2004Seltene Differentialdiagnose von EKG-Veränderungen und erhöhtem Troponin
04.03.2004Swiss Medical Forum 2004; 4:285-287
Schimke Katrin-Elisabeth, Clerici Thomas, Galeazzi Renato, Pavlicek Vojtech